Antimicrobial resistance (AMR) is a major global public health challenge. It is driven by inappropriate antimicrobial use and inadequate infection prevention and control across human, animal, plant, and environmental health settings. With resistance to second and third-line antimicrobials growing the threat is profound. Key messages for policy-makers are that:
A paradigm change is needed based on collective responsibility. National and international commitments to a “One-Health” approach offer some hope and bring sectors, disciplines, and communities together but despite years of policy discussion and much agreement, action has often been sluggish and ineffective.
Successful implementation is critical. The factors that enable it work best in combination and include
Strong leadership commitment at all levels
Clear roles, responsibilities, and accountability mechanisms
Monitoring and surveillance with rapid feedback
Multidisciplinary teams and training
Tailored targets and benchmarking at multiple levels
Reimbursement models that incentivise appropriate antimicrobial use and prevention
Educational programmes and the promotion of awareness
Adequate funding for research, and
Policies which support sustainable innovation and access to effective antibiotics.
There are key, evidence-informed interventions that countries can usefully implement
In human health settings, key measures that work include:
Antimicrobial stewardship programmes
Clinical decision support systems (CDSS) for prescribers
Control of falsified and counterfeit antimicrobials
Infection prevention and control
Vaccination to prevent the emergence and spread of key pathogens
Key effective interventions in animal health settings include:
Regulation and supervision to promote prudent use of antimicrobials
Improved biosecurity
Vaccination to prevent emergence and spread of key pathogens
Food safety compliance programmes
Key steps that can make a difference in environmental health settings include:
Improving wastewater treatment facilities
Limiting concentration of antimicrobials in discharges from the pharmaceutical industry
Improving waste management in agricultural production
Policy-makers face barriers to action including an absence of accountability mechanisms, healthcare and veterinarian staffing shortages, limited diagnostic and surveillance capacity, delayed feedback of surveillance data, misinformation on social media, shortages of essential antimicrobials and vaccines and lack of resources.
EU institutions have a key role to play from legislation, to surveillance, to technical advice. The EU adds particular value in evidence-based guidelines; the efficacy and safety of antimicrobials and vaccines; joint procurement; research funding; and in providing platforms to coordinate policy and share good practices.
Action in and by countries continues to be essential including in strengthening AMR national action plans to achieve EU-level targets. Strong leadership, balancing top-down and bottom-up interventions, optimizing the use of public resources and fostering accountability and responsiveness all support implementation at the national (and sub-national) level.
Collaboration is critical and requires suitable (and stronger) governance mechanisms at the European and global levels to foster effective links across sectors and between European, national, regional and local stakeholders.
Keeping AMR on international and national political agendas is crucial, and countries holding the Presidency of the Council of the EU can play a pivotal role in advancing this agenda.
© World Health Organization, 2024 (acting as the host organization for, and secretariat of the European Observatory on Health Systems and Policies) and OECD).